Provided by Tiger Trade Technology Pte. Ltd.

Coatue Management Holdings

4,469.64
+48.631.10%
Number of Gainers:47
Number of Losers:16
Number of Flat:1
PE:- -
High:4,483.84
Open:4,421.19
Low:4,421.19
Close:4,421.01
Volume:582.59M
Turnover:79.82B
Market Cap:14.31T
Float Cap:13.26T

Loading ...

Wall Street Opens Mixed as Investors Await Fed Minutes and Earnings Season

Deep News
·
Oct 05

Analysts Are Bullish on Top Industrial Goods Stocks: Boeing (BA), T1 Energy (TE)

TIPRANKS
·
Oct 05

AAK Expands Treasury Share Position Through Ongoing Buybacks

TIPRANKS
·
Oct 05

US Supreme Court Won't Hear Zillow's Bid to Escape Investor Class Action

Reuters
·
Oct 05

Snowflake to host Snowflake Expedition 2026

TIPRANKS
·
Oct 05

Snowflake to Host Expedition 2026 Virtual Event Featuring Satya Nadella Keynote Chat

Reuters
·
Oct 05

The Venmo Credit Card NOW Pays up to 4% Cash Back When You Split with Friends

THOMSON REUTERS
·
Oct 05

Asus Announces Amazon Prime Big Deal Days Offers with up to 54% Off

THOMSON REUTERS
·
Oct 05

Foresight to Present at the LD Micro 20th Annual Main Event Conference

GlobeNewswire
·
Oct 05

ASUS Announces Amazon Prime Big Deal Days Offers with Up to 54% Off

GlobeNewswire
·
Oct 05

Sector Update: Consumer

MT Newswires Live
·
Oct 05

Why Boeing Stock Isn't up More After Good FAA 737 MAX News

Dow Jones
·
Oct 05

The AI Boom Is Running Out of Earth. Here’s Who Benefits.

InvestorPlace
·
Oct 05

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Oct 05

US Stocks-Wall St Set for Muted Open as Tech Stocks Take a Breather

Reuters
·
Oct 05

Navitas and Microchip Collaborate to Deliver 800V Reference Design for Next-Generation AI Data Centers

GlobeNewswire
·
Oct 05

DoorDash Unit Deliveroo Partners with Coco Robotics to Launch UK Robot Deliveries

Reuters
·
Oct 05

What's Next for Tesla Stock After Strong Q3 Deliveries

Dow Jones
·
Oct 05

Coco Robotics and Deliveroo Announce Exclusive Partnership to Scale Robot Deliveries Across the UK

THOMSON REUTERS
·
Oct 05

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

GlobeNewswire
·
Oct 05